Connect your AI

Anika Therapeutics ANIK Net margin

Net margin at other companies

StrykerSYK

13.2%+0.9pp

VericelVCEL

7.3%+6.1pp

Zimmer Biomet HoldingsZBH

9.1%-2.8pp

Pacira BioSciences, Inc.PCRX

0.7%—

BioventusBVS

4.9%+3.2pp

Xtant Medical HoldingsXTNT

1.5%+0.8pp

Other financials

Income statement

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

FCF margin0.9%—

Returns & leverage

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Calculated from Anika Therapeutics’s reported figures.

net income/total revenue=-9.8%

Based on trailing twelve months.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Anika Therapeutics's net margin?: Anika Therapeutics (ANIK) reported net margin of -9.8% in Q1 2026.
How has Anika Therapeutics's net margin changed year-over-year?: Anika Therapeutics's net margin increased by 81.6% year-over-year, from -53.1% to -9.8%.
What is the long-term trend for Anika Therapeutics's net margin?: Over 4 years (2020 to 2025), Anika Therapeutics's net margin has grown at a -14.3% compound annual growth rate (CAGR), from -18.4% to -9.9%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.